Format

Send to

Choose Destination
Ann Transl Med. 2019 Sep;7(17):407. doi: 10.21037/atm.2019.07.10.

Post-operative atrial fibrillation: should we anticoagulate?

Author information

1
Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.
2
Department of Medicine, St Elizabeth's Medical Center/Tufts University School of Medicine, Boston, MA, USA.
3
Department of Internal Medicine-Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.

Abstract

The prevalence of atrial fibrillation (AF) is estimated to be 12 million by the year 2030. A subset of those patients fall into the category of post-operative atrial fibrillation (POAF) and either develop POAF after cardiac procedures [coronary artery bypass graft (CABG) and valvular procedures] or non-cardiac procedures. With the rise in surgical procedures, POAF represents a significant economic burden. POAF usually converts to sinus rhythm on its own, prompting questions about whether there is a need to treat it and if there is a need for anticoagulation. This review discusses risk factors, pathophysiology, complications of POAF, and mechanisms of risk stratifying patients to determine when to anticoagulate.

KEYWORDS:

Atrial fibrillation (AF); anticoagulation; arrhythmia; post-operative

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Publication type

Publication type

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center